Improvement of vitamin D status via daily intake of fortified yogurt drink either with or without extra calcium ameliorates systemic inflammatory biomarkers, including adipokines, in the subjects with type 2 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 6, 2012, Pages 2005-2011

  Neyestani, Tirang R ^a   Nikooyeh, Bahareh ^a   Alavi Majd, Hamid ^a   Shariatzadeh, Nastaran ^a   Kalayi, Ali ^a   Tayebinejad, Nima ^a   Heravifard, Soudabeh ^a   Salekzamani, Shabnam ^a   Zahedirad, Malihe ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; CALCIUM; FIBRINOGEN; IMMUNOGLOBULIN M; INTERLEUKIN 1BETA; INTERLEUKIN 6; RETINOL BINDING PROTEIN; VITAMIN D; YOGHURT;

ADULT; ARTICLE; BIOAVAILABILITY; BODY FAT; BODY MASS; CALCIUM INTAKE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FIBRINOGEN BLOOD LEVEL; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; VITAMIN INTAKE;

ADIPONECTIN; ADULT; BIOLOGICAL MARKERS; CALCIUM, DIETARY; CELLS, CULTURED; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; FOOD, FORTIFIED; HUMANS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; VITAMIN D; VITAMINS; YOGURT;

EID: 84861977954     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-3465     Document Type: Article

References (39)

1. Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF 2003 Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population based European Prospective Investigation into Cancer and Nutrition (EPIC) Potsdam study. Diabetes 52:812-817 (Pubitemid 36323590)
2. Kobayashi K, Inoguchi T 2005 Adipokines: therapeutic targets for metabolic syndrome. Current Drug Targets 6:525-529 (Pubitemid 40916277)
3. Nomiyama T, Perez-Tilve D, Ogawa D, Gizard F, Zhao Y, Heywood EB, Jones KL, Kawamori R, Cassis LA, Tschöp MH, Bruemmer D 2007 Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest 117:2877-2888 (Pubitemid 47529618)
4. Hansson GK, Hermansson A 2011 The immune system in atherosclerosis. Nat Immunol 12:204-212
5. Mathieu C, Adorini L 2002 The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med 8:174-179 (Pubitemid 34297090)
6. Shab-Bidar S, Neyestani TR, Djazayery A, Eshraghian MR, Houshiarrad A, Gharavi A, Kalayi A, Shariatzadeh N, Zahedirad M, Khalaji N, Haidari H 2011 Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial. BMC Med 9:125
7. Cho GJ, Park HT, Shin JH, Hur JY, Kim YT, Kim SH, Lee KW, Kim T 2009 Calcium intake is inversely associated with metabolic syndrome in postmenopausal women. Korea National Health and Nutrition Survey, 2001 and 2005. Menopause 16:992-997
8. Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, Sikaris K, Grantham N, Ebeling PR, Daly RM 2011 Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 yr: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care 34:1133-1138
9. Grey A, Gamble G, Ames R, Horne A, Mason B, Reid IR 2006 Calcium supplementation does not affect CRP levels in postmenopausal women-a randomized controlled trial. Osteoporos Int 17: 1141-1145
10. Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE, Hu FB 2006 Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29:650-656 (Pubitemid 44115368)
11. Nikooyeh B, Neyestani TR, Farvid M, Alavi-Majd H, Houshiarrad A, Kalayi A, Shariatzadeh N, Gharavi A, Heravifard S, Tayebinejad N, Salekzamani S, Zahedirad M 2011 Daily consumption of vitamin D- or vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr 93:764-771
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28:412-419 (Pubitemid 15018832)
13. Neyestani TR, Gharavi A, Kalayi A 2007 Determination of serum 25-hydroxy cholecalciferol using high-performance liquid chromatography: a reliable tool for assessment of vitamin D status. Int J Vitam Nutr Res 77:341-346 (Pubitemid 351204513)
14. Neyestani TR, Gharavi A, Kalayi A 2009 Selective effects of tea extract and its phenolic compounds on human peripheral blood mononuclear cell cytokine secretions. Int J Food Sci Nutr 60:79-88
15. Panichi V, De Pietro S, Andreini B, Bianchi AM, Migliori M, Taccola D, Giovannini L, Tetta C, Palla R 1998 Calcitriol modulates in vivo and in vitro cytokine production: a role for intracellular calcium. Kidney Int 54:1463-1469 (Pubitemid 28502888)
16. Inanir A, Ozoran K, Tutkak H, Mermerci B 2004 The effects of calcitriol therapy on serum interleukin-1, interleukin-6 and tumour necrosis factor-α concentrations in post-menopausal patients with osteoporosis. J Int Med Res 32:570-582 (Pubitemid 39561761)
17. Jorde R, Sneve M, Torjesen PA, Figenschau Y, Gøransson LG, Omdal R 2010 No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine 50:175-180
18. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R 2006 Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 83:754-759 (Pubitemid 44713136)
19. Gannagé-Yared MH, Azoury M, Mansour I, Baddoura R, Halaby G, Naaman R 2003 Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women. J Endocrinol Invest 26:748-753 (Pubitemid 37451753)
20. Cigolini M, Iagulli MP, Miconi V, Galiotto M, Lombardi S, Targher G 2006 Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 29:722-724 (Pubitemid 44115386)
21. Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe- Court D, Aganna E, Price CP, Boucher BJ 2002 Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 95:787-796 (Pubitemid 36032948)
22. Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R 2003 Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab 88:4623-4632 (Pubitemid 37357503)
23. Nagpal S, Na S, Rathnachalam R 2005 Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26:662-687 (Pubitemid 41127276)
24. Khoo AL, Chai LY, Koenen HJ, Sweep FC, Joosten I, Netea MG, van der Ven AJ 2011 Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clin Exp Immunol 164: 72-79
25. Ziemke F, Mantzoros CS, Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K 2010 Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 91:258S-261S
26. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K 2006 Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116:1784-1792 (Pubitemid 44033298)
27. Lee S, Lee DK, Choi E, Lee JW 2005 Identification of a functional vitamin D response element in the murine Insig-2 promoter and its potential role in the differentiation of 3T3-L1 preadipocytes. Mol Endocrinol 19:399-408 (Pubitemid 40223464)
28. Sun X, Zemel MB 2007 Calcium and 1,25-dihydroxyvitamin D3 regulation of adipokine expression. Obesity (Silver Spring) 15:340-348 (Pubitemid 46407314)
29. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT 2006 Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 55:249-259 (Pubitemid 43343322)
30. Banga A, Bodles AM, Rasouli N, Ranganathan G, Kern PA, Owens RJ 2008 Calcium is involved in formation of high molecular weight adiponectin. Metab Syndr Relat Disord 6:103-111 (Pubitemid 351769258)
31. Muoio DM, Newgard CB 2005 Metabolism: A is for adipokine. Nature 436:337-338 (Pubitemid 41059036)
32. Scatena M, Liaw L, Giachelli CM 2007 Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 27:2302-2309 (Pubitemid 350203943)
33. Takemoto M, Yokote K, Nishimura M, Shigematsu T, Hasegawa T, Kon S, Uede T, Matsumoto T, Saito Y, Mori S 2000 Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis. Arterioscler Thromb Vasc Biol 20:624-628 (Pubitemid 30151673)
34. Neyestani TR, Shariat-Zadeh N, Gharavi A, Kalayi A, Khalaji N 2007 The opposite associations of lycopene and body fat mass with humoral immunity in type 2 diabetes mellitus: a possible role in atherogenesis. Iran J Allergy Asthma Immunol 6:79-87 (Pubitemid 47203952)
35. Lewis MJ, Malik TH, Ehrenstein MR, Boyle JJ, Botto M, Haskard DO 2009 Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 120:417-426
36. Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom AR, Wu K, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Haverkate F, de Maat MP, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi R, Vahtera E, Jousilahti P, Pekkanen J, D'Agostino R, Kannel WB, Wilson PW, Tofler G, Arocha-Piñango CL, Rodriguez-Larralde A, Nagy E, Mijares M, Espinosa R, Rodriquez-Roa E, Ryder E, Diez-Ewald MP, Campos G, Fernandez V, Torres E, Marchioli R, Valagussa F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb JD, Rodriguez B, Yano K, Salonen JT, Nyyssönen K, Tuomainen TP, Hedblad B, Lind P, Loewel H, Koenig W, Meade TW, Cooper JA, De Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Kitamura A, Naito Y, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Després JP, Dagenais GR, Tunstall-Pedoe H, Woodward M, Ben-Shlomo Y, Davey Smith G, Palmieri V, Yeh JL, Rudnicka A, Ridker P, Rodeghiero F, Tosetto A, Shepherd J, Ford I, Robertson M, Brunner E, Shipley M, Feskens EJ, Kromhout D, Dickinson A, Ireland B, Juzwishin K, Kaptoge S, Lewington S, Memon A, Sarwar N, Walker M, Wheeler J, White I, Wood A 2005 Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 294:1799-1809 (Pubitemid 41434626)
37. Maple-Brown LJ, Cunningham J, Nandi N, Hodge A, O'Dea K 2010 Fibrinogen and associated risk factors in a high-risk population: urban Indigenous Australians, the DRUID Study. Cardiovasc Diabetol 9:69
38. Carr ME 2001 Diabetes mellitus: a hypercoagulable state. J Diabetes Complications 15:44-54 (Pubitemid 32203891)
39. Zittermann A 2003 Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 89:552-572 (Pubitemid 36592083)